Christopher J. Burns
94Patents
17h-index
124Co-inventors
87Inventor score
Filing activity: May 1, 1992 → Sep 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7593820B2 | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof | Emerging Cross-Sectional Technologies | 62 | Expired |
| US9511142B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 46 | Active |
| US7265152B2 | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases | Chemistry; Metallurgy | 43 | Expired |
| US8486941B2 | Phenyl amino pyrimidine compounds and uses thereof | Chemistry; Metallurgy | 42 | Active |
| US8461161B2 | Substituted pyrazines as inhibitors of kinase activity | Chemistry; Metallurgy | 38 | Active |
| US5750567A | Farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same | Chemistry; Metallurgy | 33 | Expired |
| US5889053A | Farnesyl transferase inhibitors, preparation thereof and pharmaceuticals compositions containing said inhibitors | Human Necessities | 33 | Expired |
| US8912169B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 30 | Active |
| US6687322B1 | Dual mode clock alignment and distribution device | Physics | 29 | Expired |
| US9040504B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 28 | Active |
| US9403850B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 22 | Active |
| US9376454B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9422314B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US8216218B2 | Treatment apparatus and methods for delivering high frequency energy across large tissue areas | Human Necessities | 20 | Active |
| US8030336B2 | Nicotinamide-based kinase inhibitors | Chemistry; Metallurgy | 18 | Active |
| US6516366B1 | Serial bus for connecting two integrated circuits with storage for input/output signals | Physics | 18 | Expired |
| US9637504B2 | Beta-lactamase inhibitors | Human Necessities | 17 | Active |
| US5920708A | Serial port having only a single terminal for information transfer to and from an integrated circuit | Physics | 15 | Expired |
| US9828391B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US8084456B2 | Pyrazine-based tubulin inhibitors | Chemistry; Metallurgy | 13 | Active |
| US9771382B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US9783555B2 | Beta-lactamase inhibitors | Human Necessities | 12 | Active |
| US7666863B2 | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases | Chemistry; Metallurgy | 11 | Active |
| US5861529A | Farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them | Chemistry; Metallurgy | 11 | Expired |
| US6057369A | Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds | Chemistry; Metallurgy | 11 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.